CharlieAJA/iStock via Getty Images Organon ( NYSE: OGN ) is scheduled to announce Q3 earnings results on Thursday, October 31st, before market open. JP Morgan does not expect any major surprise in the Q3 earnings, with the generic version of AbbVie’s ( ABBV ) Humira continuing to ramp.
Back to Health Page
